CT Low Dose Lung Cancer Screening. Part I. Journey to LDCT LCS Program

Size: px
Start display at page:

Download "CT Low Dose Lung Cancer Screening. Part I. Journey to LDCT LCS Program"

Transcription

1 CT Low Dose Lung Cancer Screening Part I Journey to LDCT LCS Program Paul Johnson, M.S., DABHP, DABR Cleveland Clinic September 26, 2015

2 Lung Caner is No. 1 In Cancer Related Death In The United States Lung cancer kills more people than breast cancer, colon cancer and prostate cancer combined 226,000 are newly diagnosed;; 160,000 die of lung cancer per year In comparison, 43,700 die of breast cancer per year Nearly 90% of lung cancers are related to smoking

3 Early Diagnosis of Lung Cancer Early diagnosis is the Only factor that improves survival From stage IA to IIIA, survival rate can drop 65% * Stanford University Healthcare Lung Cancer Screening Program.

4 Time Line of Lung Screening Events Denise R Aberle, MD, Screening Program Background and Initial Implementation AAPM 2015

5 PLCO Trial Determine the effect of screening chest radiography (CXR) on lung cancer specific mortality Randomized controlled trial of 154,901 subjects Annual P/A view CXR for 4 years or usual care Men and women aged 55 to 74;; no smoking requirement Never smokers received only 3 years of testing All subjects were followed for 13 years or until study conclusion *PLCO --- prostate, lung, colon, and ovarian

6 PLCO Trial No difference in mortality between screened and control Peter Mazzone, MD, Lung Cancer Screening

7 National Lung Screening Trial (NLST) 8/02 to 4/04: 33 US centers enrolled 53,454 people Low Dose CT: 26,722 and CXR: 26,732 More than 90% adherence to screening Rate of positive screening: LDCT: 24.2% vs. CXR: 6.9% Incidence of cancer: LDCT: 645/100,000;; CXR: 572/100,000 Deaths: LDCT: 356/100,000 vs. CXR: 443/100,000 A relative reduction of 20.0% in mortality from LDCT screening ( 95% CI 6.8 to 26.7;; p=0.004)

8 NLST Trial 20% reduction in mortality between screened and control group Peter Mazzone, MD, Lung Cancer Screening

9 CT vs. CXR For large calcified nodules, the CXR can detect equally well vs. CT

10 CT vs. CXR CXR may miss the large nodules due to overlay rib cages

11 CT vs. CXR CXR missed the non-calcified mass

12 CT detects diffuse Lung Nodules

13 CT vs. CXR: why CT scan is better? CT scan acquires tomographic image (no overlay ribs or organs) with various spatial resolution CT has better low contrast detectability (for no-calcified nodules) CT has dedicated recon kernel for lung nodules

14 NLST Guidelines for Screening Current or former smokers between years old Smoking at least 30 pack-years (for example, 2 packs a day for 15 years) Former smoker must have quit within the past 15 years

15 CMS Guidelines for Screening Asymptomatic current or former smokers between years old Smoking at least 30 pack-years Former smoker has quit smoking within the last 15 years

16 Pitfalls of CT Lung Screening Program Too many lung nodules (dilemma for radiologists) Radiation dose concerns Patient anxiety due to false positive results May give high risk patients (heavy smokers) a false assurance;; may feel protected by CT lung cancer screening, and continue smoking

17 From an International Trial Only missed 7% of cancers from 5mm to 9mm nodules

18 Based on the NLST Trial Only missed 7% of cancers from 4mm to 7mm nodules Peter Mazzone, MD, Lung Cancer Screening

19 Denise R Aberle, MD, Screening Program Background and Initial Implementation AAPM 2015

20 Difference between NLST and LungRADs Denise R Aberle, MD, Screening Program Background and Initial Implementation AAPM 2015

21 Smoking Cessation is the Key! Quit smoking at age 50 can reduce the lung cancer risk by almost 3x (300%) Peto. BMJ, 2000:321(7257)323-9

22 CT Low Dose Lung Cancer Screening Part II Scan protocols and dose tracking Frank Dong, PhD, DABR Cleveland Clinic September 26, 2015

23 CT Lung Cancer Screening Scan Parameters Scanner Gantry rotation period: 0.5s Recon Slice thickness: 2.5mm ( 1.0mm is recommended) No. of physical detector rows: 16 rows are preferred Low Radiation Dose CTDIvol <3mGy for a standard sized patient (5 7 and 154lbs) CTDIvol for smaller patients and for larger patients Use Automatic Exposure Control system if available Manual technique charts to adjust ma and/or kvp based on patient size

24 Single Breathhold To minimize respiratory motion, the CT lung screening scan should be completed within a single breathhold. ACR defined the length of a single breathhold 15s. Most CT scanners with 16 detector rows or more are capable of scanning through the entire lung (typical scan length is 30-35cm) within a single breathhold. Some 4 slice scanners may be marginally ok with 0.8s or faster gantry rotation speed, assuming the helical pitch ~1.5 is used. However, to scan through the lungs in a single breathhold and producing thin slices ( 1mm) will be a challenge for the 4-slice scanner.

25 ACR Designated Lung Screening Center Unit-specific Must have active ACR CT accreditation in chest module on designated unit(s) CT lung screening protocol form Attestation form on the ACR website Meet the requirement described in the application $400 per facility Center

26 ACR Designated Lung Screening Center Attestation form Recommended screening population Personnel qualifications Interpreting physicians Medical physicists and RT Follow up systems Structured reporting system (Lung-RADS) Smoking cessation CT Equipment QC Imaging protocol submitted Center

27 AAPM CT Lung Screening Protocols (Selected GE)

28 AAPM CT Lung Screening Protocols (Selected Siemens Sensation and Emotion)

29 AAPM CT Lung Screening Protocols (Selected Siemens Definition Family) 100kVp w/ a tin filter

30 AAPM CT Lung Screening Protocols (Selected Philips ict)

31 AAPM CT Lung Screening Protocols (Selected Toshiba)

32 CCF Lung Cancer Screening Program We have 4 designated lung cancer screening centers: the main campus, Hillcrest, Fairview and Weston (FL) The program is led by a pulmonologist Dr. Peter Mazzone 5 chest radiologists are trained to read all CT lung cancer screening studies On average, about 40 CT screening cases per month first half of Expecting the volume increases as the program expands to the regional sites. Consultation are done only at the main campus and the Weston facility

33 CCF Education Program Education is the key for the program to become standard of care and to ensure that patient expectations are realistic. Internal communication, grand rounds, lung cancer conference, satellite visits. A patient information brochure is provided at the time of order placement and at the time of the test.

34 Patient Information Brochure

35 CCF CT Protocols and Dose Tracking Low dose CT lung screening protocols are based off AAPM recommended protocols Technique parameters were adjusted due to lack of iterative reconstruction Some scanners do not have the iterative recon option Some of chest radiologists are not in favor of using IR Dose information from CT lung screening is sent to the ACR Dose Index Registry (ACR DIR) CTDIvol outliers from the lung screening CTs are tracked for quality improvement

36 CTDIvol vs. Patient Weight One site had a CT screening protocol w/ high techniques and AEC off. CTDIvol >3mGy ( 3mGy is the red horizontal line) even for small size patients (the data to the left of the green vertical line) 154lbs 3mGy

37 CTDIvol vs. Patient Weight Removed the data points from the site, CTDIvol followed patient weight in a more linear fashion. 154lbs 3mGy

38 Challenges to the Program Standardized interpretation/management Reducing false positive rates Managing the incidental findings Documenting satisfaction of CMS requirements Effectively integrating smoking cessation into the program Would negative screening results discourage smoking cessation? How to effectively target the patient group with the smoking cessation program? Maintaining costs of the program

39

Introduction and Background

Introduction and Background CT Lung Cancer Screening and the Medical Physicist: Background, Findings and Participant Dosimetry Summary of the National Lung Screening Trial (NLST) Randell Kruger, PhD, DABR Medical Physics Section

More information

Lung Cancer Screening: Current Status

Lung Cancer Screening: Current Status Lung Cancer Screening: Current Status I have no financial relationships, arrangements or affiliations and this presentation will not include discussion of investigational or off-label use of a product

More information

Outcomes in the NLST. Health system infrastructure needs to implement screening

Outcomes in the NLST. Health system infrastructure needs to implement screening Outcomes in the NLST Health system infrastructure needs to implement screening Denise R. Aberle, MD Professor of Radiology and Bioengineering David Geffen School of Medicine at UCLA 1 Disclosures I have

More information

Christine Argento, MD Interventional Pulmonology Emory University

Christine Argento, MD Interventional Pulmonology Emory University Christine Argento, MD Interventional Pulmonology Emory University Outline Lung Cancer Statistics Prior Studies for Lung Cancer Screening NLST Studies Following NLST Future Directions Lung Cancer American

More information

Lung Cancer Screening:

Lung Cancer Screening: Lung Cancer Screening: Maximizing Gain and Dealing with Pandora s Box Mark M. Fuster, MD Division of Pulmonary & Critical Care UCSD Department of Medicine & VA San Diego Healthcare Service San Diego, CA

More information

Ultralow Dose Chest CT with MBIR

Ultralow Dose Chest CT with MBIR Ultralow Dose Chest CT with MBIR Ella A. Kazerooni, M.D. Professor & Director Cardiothoracic Radiology Associate Chair for Clinical Affairs University of Michigan Disclosures Consultant: GE Healthcare

More information

Doses from Cervical Spine Computed Tomography (CT) examinations in the UK. John Holroyd and Sue Edyvean

Doses from Cervical Spine Computed Tomography (CT) examinations in the UK. John Holroyd and Sue Edyvean Doses from Cervical Spine Computed Tomography (CT) examinations in the UK John Holroyd and Sue Edyvean Why a new dose survey? Number of enquires received concerning the current NDRL Concern that could

More information

Objectives. Why? Why? Background 11/5/ % incurable disease at presentation Locally advanced disease Metastasis. 14% 5 year survival

Objectives. Why? Why? Background 11/5/ % incurable disease at presentation Locally advanced disease Metastasis. 14% 5 year survival Objectives Appraise lung cancer screening trials results Review screening guidelines Lung Cancer Screening: Past, Present and Future Chi Wan Koo, MD Koo.chiwan@mayo.edu Discuss recommendations essential

More information

LUNG CANCER: LDCT DISCLOSURES NONE. Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, /9/2018

LUNG CANCER: LDCT DISCLOSURES NONE. Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, /9/2018 LUNG CANCER: LDCT Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, 2018 DISCLOSURES 2 NONE 1 OBJECTIVES 3 Rationale and evidence for LDCT for lung cancer screening Review

More information

Screening Programs background and clinical implementation. Denise R. Aberle, MD Professor of Radiology and Engineering

Screening Programs background and clinical implementation. Denise R. Aberle, MD Professor of Radiology and Engineering Screening Programs background and clinical implementation Denise R. Aberle, MD Professor of Radiology and Engineering disclosures I have no disclosures. I have no conflicts of interest relevant to this

More information

Learning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening

Learning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening Disclosure I, Taylor Rowlett, DO NOT have a financial interest /arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context

More information

Lung Cancer Screening: Who, What, Why? Myths Dispelled

Lung Cancer Screening: Who, What, Why? Myths Dispelled Lung Cancer Screening: Who, What, Why? Myths Dispelled Presented By: MaryAnn Tateosian, RT (R), M, MM, CIIP MGH Lung Screening Program Manager December 11, 2018 1 Lung Screening Objectives History of Smoking

More information

Utilization of a Patient Dose Tracking and Monitoring System to Modify CT Protocols and Lower Patient Doses

Utilization of a Patient Dose Tracking and Monitoring System to Modify CT Protocols and Lower Patient Doses Utilization of a Patient Dose Tracking and Monitoring System to Modify CT Protocols and Lower Patient Doses Randell Kruger, Ph.D. Medical Physics and Radiation Safety Marshfield Clinic Health Systems Learning

More information

Implementation & optimization of a lung cancer screening CT program. Presented by Izabella Barreto at the 2016 Florida AAPM Chapter Meeting

Implementation & optimization of a lung cancer screening CT program. Presented by Izabella Barreto at the 2016 Florida AAPM Chapter Meeting Implementation & optimization of a lung cancer screening CT program Presented by Izabella Barreto at the 2016 Florida AAPM Chapter Meeting Izabella Barreto, Nathan Quails, Catherine Carranza, Nathalie

More information

Capturing Data Elements and the Role of Imaging Informatics

Capturing Data Elements and the Role of Imaging Informatics Capturing Data Elements and the Role of Imaging Informatics William Hsu, PhD Medical Imaging Informatics Group Dept of Radiological Sciences University of California, Los Angeles Disclosures None Overview

More information

AAPM Annual Meeting. ACR Accreditation Update in CT

AAPM Annual Meeting. ACR Accreditation Update in CT AAPM Annual Meeting ACR Accreditation Updates in CT, Ultrasound, Mammography and MRI: ACR Accreditation Update in CT Michael McNitt-Gray, PhD, DABR, FAAPM Professor, Department of Radiological Sciences

More information

SCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art

SCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art SCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art Reginald F. Munden MD, DMD, MBA I have no conflicts of interest to report National Lung Cancer Screening Trial 20% lung cancer mortality

More information

Pulmonologist s Perspective

Pulmonologist s Perspective Low-dose CT for lung cancer screening Pulmonologist s Perspective Literature Review Kang-Yun Lee, MD PhD Department of Thoracic Medicine Taipei Medical University- Shuang Ho Hospital Taiwan Local vs. Advanced

More information

Disclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures

Disclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures Updates in Lung Cancer Screening Disclosures No Financial Disclosures Neil Trivedi, MD Associate Professor of Clinical Medicine SF VAMC Pulmonary and Critical Care Director, Bronchoscopy & Interventional

More information

Lung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health

Lung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health Lung Cancer Screening Eric S. Papierniak, DO NF/SG VHA UF Health Overview Background Supporting evidence Guidelines Practical considerations Patient selection What to do with abnormal results Billing/coding

More information

Original Article Thoracic Imaging

Original Article Thoracic Imaging Original Article Thoracic Imaging https://doi.org/10.3348/kjr.2018.19.6.1179 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2018;19(6):1179-1186 Size-Specific Dose Estimation In the Korean Lung Cancer

More information

Original Article Thoracic Imaging

Original Article Thoracic Imaging Original Article Thoracic Imaging https://doi.org/10.3348/kjr.2018.19.4.803 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2018;19(4):803-808 Radiological Report of Pilot Study for the Korean Lung Cancer

More information

Criteria USPSTF CMS. Frequency Annual screening Annual screening. No signs or symptoms of lung cancer

Criteria USPSTF CMS. Frequency Annual screening Annual screening. No signs or symptoms of lung cancer Lung Cancer Screening Guidelines with low- dose computed tomography (LDCT): USPSTF and CMS February 6, 2015 Kentucky Cancer Consortium and Kentucky LEADS Component 3 Jennifer Redmond Knight, DrPH, jredknight@kycancerc.org

More information

Goals of Presentation

Goals of Presentation Goals of Presentation Review context of lung cancer screening why is it important? Review data from NLST supporting screening with lowdose CT (LDCT) scanning Discuss the pros and cons of LDCT screening

More information

Kish chakrabarti, Ph.D. Senior Physicist CDRH/FDA

Kish chakrabarti, Ph.D. Senior Physicist CDRH/FDA Facility Certification Extension Requirements, Quality Assurance and Medical Physicists role for Hologic Selenia Dimensions Digital Breast Tomosynthesis (DBT) System Kish chakrabarti, Ph.D. Senior Physicist

More information

Example of lung screening

Example of lung screening Justification of the use of CT for individual health assessment of asymptomatic people How to obtain evidence for IHA - Example of lung screening Mathias Prokop, MD PhD Professor of Radiology Radboud University

More information

Low Dose CT Lung Screening: What is Technically Required?

Low Dose CT Lung Screening: What is Technically Required? Low Dose CT Lung Screening: What is Technically Required? COMP/CCPM Annual Scientific Meeting Ottawa, Ontario July 15 th, 2017 Yogesh Thakur, PhD, MCCPM Medical Physicist Lead and Regional RSO (X-Ray)

More information

Charles Mulligan, MD, FACS, FCCP 26 March 2015

Charles Mulligan, MD, FACS, FCCP 26 March 2015 Charles Mulligan, MD, FACS, FCCP 26 March 2015 Review lung cancer statistics Review the risk factors Discuss presentation and staging Discuss treatment options and outcomes Discuss the status of screening

More information

Lung Cancer Screening

Lung Cancer Screening Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at

More information

CLINICAL GUIDELINES. Lung-Cancer Screening Program Guidelines Robert Y. Kanterman, M.D. and Thomas J. Gilbert, M.D., M.P.P.

CLINICAL GUIDELINES. Lung-Cancer Screening Program Guidelines Robert Y. Kanterman, M.D. and Thomas J. Gilbert, M.D., M.P.P. CLINICAL GUIDELINES Lung-Cancer Screening Program Guidelines Robert Y. Kanterman, M.D. and Thomas J. Gilbert, M.D., M.P.P. 3/14/2015 Introduction: The purpose of a lung-cancer screening program is to detect

More information

Toshiba Aquillion 64 CT Scanner. Phantom Center Periphery Center Periphery Center Periphery

Toshiba Aquillion 64 CT Scanner. Phantom Center Periphery Center Periphery Center Periphery Comparison of radiation dose and imaging performance for the standard Varian x-ray tube and the Richardson Healthcare ALTA750 replacement tube for the Toshiba Aquillion CT scanners. by Robert L. Dixon,

More information

Lung Cancer Screening In High Risk Populations:

Lung Cancer Screening In High Risk Populations: Lung Cancer Screening In High Risk Populations: Michael Jaklitsch, M.D. Co-Chair of AATS Task Force on Lung Cancer Screening and Surveillance From the Brigham and Women s Hospital Harvard Medical School.

More information

Lung Cancer Screening

Lung Cancer Screening Lung Cancer Screening Steven Leh, MD, FCCP Diplomat of the American Association for Bronchology and Interventional Pulmonology Aurora Medical Group Pulmonary and Sleep Medicine February 10, 2018 Disclosures

More information

8/1/2017. Financial Disclosures. Dose Tracking at MGH. How Dose Tracking Affected Protocol Optimization in a Tertiary Quaternary Healthcare Center

8/1/2017. Financial Disclosures. Dose Tracking at MGH. How Dose Tracking Affected Protocol Optimization in a Tertiary Quaternary Healthcare Center How Dose Tracking Affected Protocol Optimization in a Tertiary Quaternary Healthcare Center Mannudeep K. Kalra, MD Webster Center for Quality and Safety Massachusetts General Hospital Harvard Medical School

More information

Implementation of the 2012 ACR CT QC Manual in a Community Hospital Setting BRUCE E. HASSELQUIST, PH.D., DABR, DABSNM ASPIRUS WAUSAU HOSPITAL

Implementation of the 2012 ACR CT QC Manual in a Community Hospital Setting BRUCE E. HASSELQUIST, PH.D., DABR, DABSNM ASPIRUS WAUSAU HOSPITAL Implementation of the 2012 ACR CT QC Manual in a Community Hospital Setting BRUCE E. HASSELQUIST, PH.D., DABR, DABSNM ASPIRUS WAUSAU HOSPITAL Conflict of Interest Disclaimer Employee of Aspirus Wausau

More information

Lung Cancer Screening

Lung Cancer Screening Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at

More information

Crowd-Sourcing Quality in Imaging

Crowd-Sourcing Quality in Imaging Crowd-Sourcing Quality in Imaging Ricardo S. Avila rick.avila@accumetra.com April 20, 2017 2017 Dialog For Action on Cancer Screening and Prevention Image Quality For Lung Cancer Screening Since 2015:

More information

Debra Pennington, MD Director of Imaging Dell Children s Medical Center

Debra Pennington, MD Director of Imaging Dell Children s Medical Center Debra Pennington, MD Director of Imaging Dell Children s Medical Center 1 Gray (Gy) is 1 J of radiation energy/ 1 kg matter (physical quantity absorbed dose) Diagnostic imaging doses in mgy (.001 Gy)

More information

Why is CT Dose of Interest?

Why is CT Dose of Interest? Why is CT Dose of Interest? CT usage has increased rapidly in the past decade Compared to other medical imaging CT produces a larger radiation dose. There is direct epidemiological evidence for a an increase

More information

BrightSpeed Elite CT with ASiR: Comparing Dose & Image Quality Rule Out Pulmonary Embolism on Initial & Follow-Up Exam

BrightSpeed Elite CT with ASiR: Comparing Dose & Image Quality Rule Out Pulmonary Embolism on Initial & Follow-Up Exam GE Healthcare BrightSpeed Elite CT with ASiR: Comparing Dose & Image Quality Rule Out Pulmonary Embolism on Initial & Follow-Up Exam Michael Swack, MD Diagnostic Radiologist Irvington Radiologists, PC

More information

SCREENING FOR EARLY LUNG CANCER. Pang Yong Kek

SCREENING FOR EARLY LUNG CANCER. Pang Yong Kek SCREENING FOR EARLY LUNG CANCER Pang Yong Kek Lecture Outline Why performing screening? How to improve early detection? Benefits and Risks of screening Challenges in screening Conclusion Why Performing

More information

CT Screening for Lung Cancer for High Risk Patients

CT Screening for Lung Cancer for High Risk Patients CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients

More information

LUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC

LUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC : THE TIME HAS COME Physician Leader, Lung Cancer Multi-Disciplinary Program Fletcher Allen Health Care Annual Meeting Montpelier, VT - April 25, 2014 Gerald S. Davis, MD Professor of Medicine University

More information

Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned

Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned Jane Kim, MD, MPH Acting Chief Consultant for Preventive Medicine National Center for Health Promotion

More information

None

None 2014 None rosemary clooney Cancer is one of the most common diseases in the developed world: 1 in 4 deaths are due to cancer 1 in 17 deaths are due to lung cancer Lung cancer is the most common

More information

HI-Res Extremity Sensation 16

HI-Res Extremity Sensation 16 Page 1 Routine Extremity - (2/14/2013) CTDI: ~20 mgy per acquisition Used for evaluation of: Humerus Forearm Femur Knee Tib/Fib Billing: 1. CT Upper/Lower Extremity of concern without contrast, with contrast,

More information

Ann Intern Med. 2012;156(5):

Ann Intern Med. 2012;156(5): Lung Cancer Screening Update Doug Arenberg, M.D. University of Michigan Outline Screening; Some simple but necessary truths Do people benefit from screening? What are the harms (and are they outweighed

More information

VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening

VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening ATS San Francisco 2016 James K. Brown MD 1, Kathryn L. Rice, MD 2 (1) San Francisco VA (2) Minneapolis VAMC Disclosures

More information

BICOE Breast Imaging Center of Excellence. What is it? - Requirements. National Mammography Database. What do you get? ACR Accreditation in:

BICOE Breast Imaging Center of Excellence. What is it? - Requirements. National Mammography Database. What do you get? ACR Accreditation in: BICOE Breast Imaging Center of Excellence What is it? - Requirements William Geiser, MS DABR Senior Medical Physicist MD Anderson Cancer Center Houston, Texas wgeiser@mdanderson.org ACR Accreditation in:

More information

Lung Cancer Screening: To screen or not to screen?

Lung Cancer Screening: To screen or not to screen? Lung Cancer Screening: To screen or not to screen? Dan J. Raz, M.D. Co Director, Lung Cancer Screening Program Co Director, LungCancer and Thoracic OncologyProgram Assistant Professor, Thoracic Surgery

More information

SHARED DECISION MAKING AND LUNG CANCER SCREENING

SHARED DECISION MAKING AND LUNG CANCER SCREENING SHARED DECISION MAKING AND LUNG CANCER SCREENING DISCLOSURES Cathleen E. Morrow, MD None William C. Black, MD No financial disclosure Co-investigator for NLST Member of the ACR Lung-RADS Screening Registry

More information

Lung Cancer Screening Benefits, Risks & Challenges

Lung Cancer Screening Benefits, Risks & Challenges Lung Cancer Screening Benefits, Risks & Challenges Polly Sather, APRN Yale Lung Screening and Nodule Program (Yale Lung SCAN) A Multidisciplinary Comprehensive Initiative Yale Cancer Center Thoracic Oncology

More information

Accounting for Imaging Dose

Accounting for Imaging Dose Accounting for Imaging Dose High Profile Over-exposures Lead to Growing Concern FDA issues warning in October 2009-209 patients exposed to 8 times typical dose for CT brain perfusion scan (3-4 Gy) - Some

More information

ESTABLISHING DRLs in PEDIATRIC CT. Keith Strauss, MSc, FAAPM, FACR Cincinnati Children s Hospital University of Cincinnati College of Medicine

ESTABLISHING DRLs in PEDIATRIC CT. Keith Strauss, MSc, FAAPM, FACR Cincinnati Children s Hospital University of Cincinnati College of Medicine ESTABLISHING DRLs in PEDIATRIC CT Keith Strauss, MSc, FAAPM, FACR Cincinnati Children s Hospital University of Cincinnati College of Medicine CT Dose Indices CTDI INTRODUCTION CTDI 100, CTDI w, CTDI vol

More information

A Comprehensive Cancer Center Designated by the National Cancer Institute

A Comprehensive Cancer Center Designated by the National Cancer Institute N C I C C C A Comprehensive Cancer Center Designated by the National Cancer Institute Screening and Early Detection of Lung Cancer: Ready for Practice? David S. Ettinger, MD, FACP, FCCP Alex Grass Professor

More information

BICOE Stereotactic Breast Biopsy and Breast Ultrasound Accreditation. Introduction. Educational Objectives

BICOE Stereotactic Breast Biopsy and Breast Ultrasound Accreditation. Introduction. Educational Objectives BICOE Stereotactic Breast Biopsy and Breast Ultrasound Accreditation William Geiser, MS DABR Senior Medical Physicist MD Anderson Cancer Center Houston, Texas wgeiser@mdanderson.org 1 Introduction Objectives

More information

CT Head Dose Reduction Using Spiral Scanning Protocol

CT Head Dose Reduction Using Spiral Scanning Protocol CT Head Dose Reduction Using Spiral Scanning Protocol Reed, William J MD; Broderick, Daniel F, MD; Weindling, Steven M, MD; Czervionke, Leo F MD; and Morin, Richard L; PhD; Mayo Clinic, Department of Radiology;

More information

X-Ray & CT Physics / Clinical CT

X-Ray & CT Physics / Clinical CT Computed Tomography-Basic Principles and Good Practice X-Ray & CT Physics / Clinical CT INSTRUCTORS: Dane Franklin, MBA, RT (R) (CT) Office hours will be Tuesdays from 5pm to 6pm CLASSROOM: TIME: REQUIRED

More information

Current Approach to Screening for Lung Cancer. James R Jett M.D.

Current Approach to Screening for Lung Cancer. James R Jett M.D. Current Approach to Screening for Lung Cancer James R Jett M.D. Potential Conflicts of Interest I am Chief Medical Officer for Oncimmune Ltd (Biomarkers of Cancer) Co-Editor of Lung Cancer Section of UP-TO-DATE

More information

MR QA/QC for MRgRT. Rick Layman, PhD, DABR Department of Radiology July 13, 2015

MR QA/QC for MRgRT. Rick Layman, PhD, DABR Department of Radiology July 13, 2015 MR QA/QC for MRgRT Rick Layman, PhD, DABR Department of Radiology July 13, 2015 The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

More information

DISCLOSURE. Lung Cancer Screening: The End of the Beginning. Learning Objectives. Relevant Financial Relationship(s) Off Label Usage

DISCLOSURE. Lung Cancer Screening: The End of the Beginning. Learning Objectives. Relevant Financial Relationship(s) Off Label Usage Peninsula Regional Medical Center 12 th Annual Lung Cancer Conference March 9, 2017 Lung Cancer Screening: The End of the Beginning David E. Midthun M.D. Professor of Medicine College of Medicine, Mayo

More information

Lung cancer screening in Switzerland

Lung cancer screening in Switzerland SAMO Interdisciplinary Workshop on Chest Tumors 27 th and 28 th January 2017 Hotel Hermitage, Lucerne Lung cancer screening in Switzerland Walter Weder, MD, Professor of Surgery University Hospital Zurich,

More information

BICOE Stereotactic Breast Biopsy and Breast Ultrasound Accreditation. Introduction. Educational Objectives

BICOE Stereotactic Breast Biopsy and Breast Ultrasound Accreditation. Introduction. Educational Objectives BICOE Stereotactic Breast Biopsy and Breast Ultrasound Accreditation William Geiser, MS DABR Senior Medical Physicist MD Anderson Cancer Center Houston, Texas wgeiser@mdanderson.org 1 Introduction Objectives

More information

Lung Cancer Screening: Benefits and limitations to its Implementation

Lung Cancer Screening: Benefits and limitations to its Implementation Lung Cancer Screening: Benefits and limitations to its Implementation Rolando Sanchez, MD Clinical Assistant Professor Pulmonary-Critical Care Medicine University of Iowa Lung cancer - Epidemiology Cancer

More information

CT Quality Control Manual FAQs

CT Quality Control Manual FAQs CT Quality Control Manual FAQs General Question: How often will the QC Manual be updated and how will those updates be communicated? Answer: The ACR CT Physics Subcommittee will review any comments, issues

More information

Hi RES Extremity - (04/18/2011) CTDI: ~13 mgy per acquisition Used for evaluation of: Ankle Elbow Hand Wrist Foot /Calcaneous Toes Fingers

Hi RES Extremity - (04/18/2011) CTDI: ~13 mgy per acquisition Used for evaluation of: Ankle Elbow Hand Wrist Foot /Calcaneous Toes Fingers P a g e 1 Hi RES Extremity - (04/18/2011) CTDI: ~13 mgy per acquisition Used for evaluation of: Ankle Elbow Hand Wrist Foot /Calcaneous Toes Fingers Billing: 1. CT Upper/Lower Extremity of concern without

More information

The National Lung Screening Trial (NLST)

The National Lung Screening Trial (NLST) The National Lung Screening Trial (NLST) Pamela Marcus US National Cancer Institute May 21, 2012 Today s talk NLST: an overview Typical challenges in cancer screening RCTs Starting ti a trial in the presence

More information

Lung Cancer and CT Screening

Lung Cancer and CT Screening Lung Cancer and CT Screening Samer Kanaan, MD February 17 th, 2012 Goals Understand the Societal impact of Lung Cancer Identify Risk Factors for Lung Cancer List Diagnostic Tests Available for Lung Cancer

More information

Screening for Lung Cancer. Michael S. Nolledo, MD Deborah Heart and Lung Center

Screening for Lung Cancer. Michael S. Nolledo, MD Deborah Heart and Lung Center Screening for Lung Cancer Michael S. Nolledo, MD Deborah Heart and Lung Center 1 1 Outline Ø Introduction Ø Lung Cancer Screening pre-2010 Ø Lung Cancer Screening today 2 2 Lung Cancer 2011 (Siegel et

More information

Low-Dose CT Cancer Screening Program

Low-Dose CT Cancer Screening Program Low-Dose CT Cancer Screening Program 1 History of Low-Dose CT Screening In 2011, the National Lung Screening Trial (NLST) was the first trial that provided evidence based support that Low-Dose CT (LDCT)

More information

Robert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center

Robert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center You Smoke, You Get Lung Cancer, You Die: Can Screening Change this Paradigm? Robert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center AATS Saturday 4/28/2012 Cancer Screening Cancer

More information

Update on MQSA and Mammography Accreditation

Update on MQSA and Mammography Accreditation MQSA - Who s Who Update on MQSA and Mammography Accreditation The Law: Mammography Quality Standards Act (MQSA) The Regulator: US Food and Drug Administration (FDA) Priscilla F. Butler, M.S. Senior Director,

More information

LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS?

LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS? LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS? DAVID O. WILSON, MD, MHP DIRECTOR GEORGIA COOPER MEMORIAL LUNG CANCER RESEARCH REGISTRY UNIVERSITY OF PITTSBURGH

More information

What to know and what to make of it

What to know and what to make of it Lung Cancer Screening: What to know and what to make of it J. Matthew Reinersman, MD Assistant Professor of Surgery Division of Thoracic and Cardiovascular Surgery Department of Surgery University of Oklahoma

More information

CT Chest HRCT CT Chest WO

CT Chest HRCT CT Chest WO CT Chest HRCT CT Chest WO Reviewed By: Anna Ellermeier, MD; Brett Mollard, MD Last Reviewed: August 2018 Contact: (866) 761-4200, Option 1 In accordance with the ALARA principle, TRA policies and protocols

More information

Acknowledgments. A Specific Diagnostic Task: Lung Nodule Detection. A Specific Diagnostic Task: Chest CT Protocols. Chest CT Protocols

Acknowledgments. A Specific Diagnostic Task: Lung Nodule Detection. A Specific Diagnostic Task: Chest CT Protocols. Chest CT Protocols Personalization of Pediatric Imaging in Terms of Needed Indication-Based Quality Per Dose Acknowledgments Duke University Medical Center Ehsan Samei, PhD Donald Frush, MD Xiang Li PhD DABR Cleveland Clinic

More information

NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening

NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening 444 Original Research NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening Brady J. McKee, MD; Shawn Regis, PhD; Andrea K. Borondy-Kitts, MS, MPH; Jeffrey A. Hashim, MD; Robert J.

More information

CT Lung Screening Implementation Challenges: State Based Initiatives

CT Lung Screening Implementation Challenges: State Based Initiatives CT Lung Screening Implementation Challenges: State Based Initiatives Andrea McKee, MD Chair Radiation Oncology Lahey Hospital and Medical Center Co-Director Rescue Lung, Rescue Life Program Co-Chair Massachusetts

More information

Cardiac CT - Coronary Calcium Basics Workshop II (Basic)

Cardiac CT - Coronary Calcium Basics Workshop II (Basic) Cardiac CT - Coronary Calcium Basics Workshop II (Basic) J. Jeffrey Carr, MD, MSCE Dept. of Radiology & Public Health Sciences Wake Forest University School of Medicine Winston-Salem, NC USA No significant

More information

SPECIFIC PRINCIPLES FOR DOSE REDUCTION IN HEAD CT IMAGING. Rajiv Gupta, MD, PhD Neuroradiology, Massachusetts General Hospital Harvard Medical School

SPECIFIC PRINCIPLES FOR DOSE REDUCTION IN HEAD CT IMAGING. Rajiv Gupta, MD, PhD Neuroradiology, Massachusetts General Hospital Harvard Medical School SPECIFIC PRINCIPLES FOR DOSE REDUCTION IN HEAD CT IMAGING Rajiv Gupta, MD, PhD Neuroradiology, Massachusetts General Hospital Harvard Medical School OUTLINE 1 st Presentation: Dose optimization strategies

More information

Estimated Radiation Dose Associated With Low-Dose Chest CT of Average-Size Participants in the National Lung Screening Trial

Estimated Radiation Dose Associated With Low-Dose Chest CT of Average-Size Participants in the National Lung Screening Trial Medical Physics and Informatics Original Research Larke et al. Estimated Radiation Dose for Low-Dose Chest CT Medical Physics and Informatics Original Research Frederick J. Larke 1 Randell L. Kruger 2

More information

Translating Protocols Across Patient Size: Babies to Bariatric

Translating Protocols Across Patient Size: Babies to Bariatric Translating Protocols Across Patient Size: Babies to Bariatric Cynthia H. McCollough, PhD, FACR, FAAPM Professor of Radiologic Physics Director, CT Clinical Innovation Center Department of Radiology Mayo

More information

National Lung Screening Trial Results

National Lung Screening Trial Results National Lung Screening Trial Results Ella A. Kazerooni, M.D. Professor & Director Cardiothoracic Radiology Associate Chair for Clinical Affairs University of Michigan NLST STOPPED! Lung cancer trial results

More information

(Non-EKG Gated) CTA Thoracic Aorta = CTA Chest

(Non-EKG Gated) CTA Thoracic Aorta = CTA Chest (Non-EKG Gated) CTA Thoracic Aorta = CTA Chest Reviewed By: Dan Verdini, MD, Rachael Edwards, MD Last Reviewed: January 2019 Contact: (866) 761-4200, Option 1 In accordance with the ALARA principle, TRA

More information

8/18/2011. Acknowledgements. Managing Pediatric CT Patient Doses INTRODUCTION

8/18/2011. Acknowledgements. Managing Pediatric CT Patient Doses INTRODUCTION Managing Pediatric CT Patient Doses Keith J. Strauss, MSc, FAAPM, FACR President X-Ray Computations, Inc. Boston, Massachusetts Acknowledgements Marilyn Goske, MD John Boone, PhD Cynthia McCollough, PhD

More information

Low-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2

Low-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2 Low-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2 The Committee for Management of CT-screening-detected Pulmonary Nodules 2009-2011 The Japanese Society of CT Screening

More information

ACR MRI Accreditation: Medical Physicist Role in the Application Process

ACR MRI Accreditation: Medical Physicist Role in the Application Process ACR MRI Accreditation: Medical Physicist Role in the Application Process Donna M. Reeve, MS, DABR, DABMP Department of Imaging Physics University of Texas M.D. Anderson Cancer Center Educational Objectives

More information

IEHP UM Subcommittee Approved Authorization Guidelines CT Screening (Low Dose) for Lung Cancer

IEHP UM Subcommittee Approved Authorization Guidelines CT Screening (Low Dose) for Lung Cancer CT Screening (Low Dose) for Lung Cancer Policy: There is currently adequate evidence that using low dose computed tomography (LDCT) to screen asymptomatic individuals who are at risk for lung cancer improves

More information

Selected Controversies. Cancer Screening. Breast Cancer Screening. Selected Controversies. Page 1. Using Best Evidence to Guide Practice

Selected Controversies. Cancer Screening. Breast Cancer Screening. Selected Controversies. Page 1. Using Best Evidence to Guide Practice Cancer Screening Using Best Evidence to Guide Practice Judith M.E. Walsh, MD, MH Division of General Internal Medicine Women s Health Center of Excellence University of California, San Francisco Selected

More information

Radiation Dosimetry for CT Protocols

Radiation Dosimetry for CT Protocols Radiation Dosimetry for CT Protocols This document contains radiation dosimetry information from CT scans and can be used by investigators to estimate the dosimetry information required by the JRSC or

More information

CT Radiation Risks and Dose Reduction

CT Radiation Risks and Dose Reduction CT Radiation Risks and Dose Reduction Walter L. Robinson, M.S. D.A.B.S.N.M., D.A.B.M.P., D.A.B.R. Consultant Certified Medical Radiation Health & Diagnostic Imaging Physicist Medical Radiation and Children

More information

CT screening for lung cancer. Should it be done in the Indian context?

CT screening for lung cancer. Should it be done in the Indian context? CT screening for lung cancer Should it be done in the Indian context? Wilson and Jungner screening criteria 1. The condition sought should be an important health problem. 2. There should be an accepted

More information

A Summary from the 2013World Conference on Lung Cancer Sydney, Australia

A Summary from the 2013World Conference on Lung Cancer Sydney, Australia A Summary from the 2013World Conference on Lung Cancer Sydney, Australia In 2011, the U.S. National Lung Screening Trial (NLST) has demonstrated that low-dose computed tomography (LDCT) screening of high

More information

Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial

Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial Cardiopulmonary Imaging Original Research Pinsky et al. Lung Cancer Risk Associated With New Nodules Cardiopulmonary Imaging Original Research Paul F. Pinsky 1 David S. Gierada 2 P. Hrudaya Nath 3 Reginald

More information

DOH LUNG CANCER SCREENING SERVICE SPECIFICATIONS

DOH LUNG CANCER SCREENING SERVICE SPECIFICATIONS DOH LUNG CANCER SCREENING SERVICE SPECIFICATIONS December 2018 Page 1 of 18 Document Title: Document Ref. Number: DOH Lung Cancer Screening Service Specifications PH/NCD/LCSC/SR/0.9 Version: 0.9 Approval

More information

VA PARTNERSHIP Increase ACCESS to LUNG SCREENING

VA PARTNERSHIP Increase ACCESS to LUNG SCREENING VA PARTNERSHIP Increase ACCESS to LUNG SCREENING Project PI: Drew Moghanaki, MD, MPH Clinical Co-PI: Claudia Henschke, PhD, MD Technical Co-PI: Rick Avila, MS Sponsored by the Bristol-Myers Squibb Foundation

More information

Faculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky

Faculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky Lung Cancer in Kentucky: Improving Patient Outcomes Faculty Disclosure The presenter and members of the development team do not have any conflicts to report. Celeste T. Worth, MCHES Kentucky Collaborative

More information

CANCER Annual Report

CANCER Annual Report 2016 CANCER Annual Report A WORD FROM OUR LEADERSHIP We are pleased to present our 2016 Annual Report highlighting advances in state of the art cancer care at the Roper St. Francis Cancer Program. Our

More information

Screening for Lung Cancer - State of the Art

Screening for Lung Cancer - State of the Art Screening for Lung Cancer - State of the Art Rohit Kumar, MD Assistant Professor of Medicine Fox Chase Cancer Center Temple University School of Medicine Philadelphia, PA Objectives Review current evidence

More information